Hims & Hers Health Inc (NYSE:HIMS) has seen its stock drop 21% to $25.73 over the past month, driven by regulatory updates from the FDA regarding tirzepatide injection shortages. However, the stock remains up over 200% over the past year, reflecting strong earnings performance.
What To Know: The company reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst expectations of 4 cents. Revenue rose 77% year-over-year to $401.6 million, beating estimates of $382.2 million.
Subscriber growth surged 44%, reaching 2 million, and net income soared to $75.6 million, compared to a net loss of $7.6 million last year. However, gross margins narrowed slightly to 79%, down from 83% a year ago.
CEO Andrew Dudum highlighted the company's continued momentum, noting its focus on delivering accessible, personalized care. Hims & Hers raised its fiscal 2024 revenue outlook to $1.46-$1.465 billion, indicating confidence in sustained growth.
Investor sentiment has otherwise been tempered over the past month by the FDA's resolution of the tirzepatide shortage, which may pressure demand for compounded alternatives. Despite this, ongoing shortages of other GLP-1 drugs and strong fundamentals could position Hims & Hers for potential long-term success.
Read Also: US 2025 Recession Odds Plummet: Good News Or Warning Sign?
How To Buy HIMS Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange-traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Hims & Hers Health's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from Benzinga Pro, Hims & Hers has a 52-week high of $35.02 and a 52-week low of $8.14.
It closed Wednesday down more than 7% at $25.73.
Now Read:
- 5 Dead, Nearly 180,000 Evacuated In Los Angeles Wildfires: California Utilities Face Scrutiny
Image: Shutterstock
